Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes.

Ingallinella P, Peier AM, Pocai A, Marco AD, Desai K, Zytko K, Qian Y, Du X, Cellucci A, Monteagudo E, Laufer R, Bianchi E, Marsh DJ, Pessi A.

Bioorg Med Chem. 2012 Aug 1;20(15):4751-9. doi: 10.1016/j.bmc.2012.06.003. Epub 2012 Jun 9.

PMID:
22771182
2.

Synthesis and evaluation of novel phosphoramidate prodrugs of 2'-methyl cytidine as inhibitors of hepatitis C virus NS5B polymerase.

Donghi M, Attenni B, Gardelli C, Marco AD, Fiore F, Giuliano C, Laufer R, Leone JF, Pucci V, Rowley M, Narjes F.

Bioorg Med Chem Lett. 2009 Mar 1;19(5):1392-5. doi: 10.1016/j.bmcl.2009.01.035. Epub 2009 Jan 19.

PMID:
19181520
3.

HIV/AIDS risk among female sex workers who use crack in Southern Brazil.

Malta M, Monteiro S, Lima RM, Bauken S, Marco Ad, Zuim GC, Bastos FI, Singer M, Strathdee SA.

Rev Saude Publica. 2008 Oct;42(5):830-7.

4.

[Evidence based cardiology].

Victor EG, Marco Ad.

Arq Bras Cardiol. 2004 Oct;83(4):355-6. Epub 2004 Oct 22. Portuguese. No abstract available.

5.

Use of the dopamine agonist cabergoline in the treatment of movement disorders.

Marco AD, Appiah-Kubi LS, Chaudhuri KR.

Expert Opin Pharmacother. 2002 Oct;3(10):1481-7. Review.

PMID:
12387694
6.

A new method for chemoselective conjugation of unprotected peptides to dauno- and doxorubicin.

Ingallinella P, Marco AD, Taliani M, Fattori D, Pessi A.

Bioorg Med Chem Lett. 2001 May 21;11(10):1343-6.

PMID:
11392551
7.

How adequate are warnings and first and instructions on consumer product labels?: an investigation.

Alderman D, Burke M, Cohen B, Di Marco AD, Fiet S, Hertzberg L, Sandor P.

Vet Hum Toxicol. 1982 Feb;24(1):8-11.

PMID:
7058630
8.

Histological and histochemical investigations of achondroplastic mice: a possible model of human achondroplasia.

Bonucci E, Marco AD, Nicoletti B, Petrinelli P, Pozzi L.

Growth. 1976 Sep;40(3):241-51.

PMID:
976768

Supplemental Content

Loading ...
Support Center